Moxifloxacin Holsten

Moxifloxacin, the active ingredient in Moxifloxacin Holsten, is a fluoroquinolone antibiotic presented as an oral tablet for systemic use. It treats bacterial infections such as community‑acquired pneumonia, acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and skin and skin structure infections in adult patients.

GNH USA supplies Moxifloxacin Holsten as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacin is a fluoroquinolone antibiotic used to treat bacterial infections of the respiratory tract and skin. - Community‑acquired pneumonia: achieves bacterial eradication and clinical cure in adult patients. - Acute bacterial sinusitis: reduces symptoms and promotes resolution of sinus infection. - Acute bacterial exacerbations of chronic bronchitis: improves lung function and shortens disease duration. - Skin and skin structure infections: clears infection and supports wound healing.

Moxifloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild stomach upset occurring in many patients. - Diarrhea: loose stools, usually self‑limiting. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Abdominal pain: discomfort in the stomach area. - Rash: mild skin redness or itching.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon tear, especially Achilles. - QT interval prolongation: risk of cardiac arrhythmia. - Clostridioides difficile infection: severe colitis. - Severe allergic reactions: anaphylaxis or angioedema. - Hepatic toxicity: elevated liver enzymes or hepatitis. - Photosensitivity: heightened skin reaction to sunlight.

Before prescribing Moxifloxacin, clinicians should consider several precautionary measures. - Renal impairment: evaluate kidney function and adjust therapy if necessary. - History of tendon disorders: avoid use in patients with prior tendon injury. - QT prolongation risk: monitor ECG in patients with cardiac risk factors. - Pregnancy and lactation: prescribe only when benefits outweigh potential risks. - Drug interactions: review concomitant medications for possible interactions. - Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Moxifloxacin can interact with other medicines, affecting safety or effectiveness.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: reduce oral absorption of moxifloxacin. - Other fluoroquinolones: increase risk of tendon toxicity. - Warfarin: may enhance anticoagulant effect and bleeding risk. - Systemic corticosteroids: heightened chance of tendon rupture.

Moderate Interactions (Monitor Closely): - Theophylline: moxifloxacin may raise serum theophylline levels. - NSAIDs: concurrent use can increase central nervous system stimulation. - Diabetes medications: may alter glucose control, requiring monitoring.